United States Pharmaceuticals

Annexon Inc (ANNX)

Track

Over the past 90 days, Annexon Inc. saw four insider transactions, resulting in a net positive value of approximately $3.32 million. The activity was dominated by a significant purchase in late May. While some former directors engaged in minor proposed sales, there has been no net selling activity from current executives during this period.
Ticker: ANNX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Annexon Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 15 Jul 2026
Value US$4,792,251.09 | Price 194.82 | Shares 52,761
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-15 PrS Proposed sale
2.7
WIGGANS THOMAS G

Former Director

Non-Executive Director
52,761
194.82
US$4,792,251 		52,761 194.82 US$4,792,251
2026-07-14 2026-07-14 PrS Proposed sale
2.7
WIGGANS THOMAS G

Former Director

Non-Executive Director
43,071
173.91
US$4,019,001 		43,071 173.91 US$4,019,001
2026-05-29 2026-05-28 B Purchase
3.3
Satter Muneer A
Non-Executive Director
1,665 -49.6%
246.41
US$2,647,596 		1,665 -49.6% 246.41 US$2,647,596
2026-05-13 2026-05-11 PP Planned purchase
Carson William H.
Non-Executive Director
8,000 +11.4%
5.78
US$46,240 		8,000 +11.4% 5.78 US$46,240
2026-04-14 2026-04-10 PP Planned purchase
Carson William H.
Non-Executive Director
8,000 +12.8%
6.20
US$49,600 		8,000 +12.8% 6.20 US$49,600
2026-03-12 2026-03-10 PP Planned purchase
Carson William H.
Non-Executive Director
8,000 +14.7%
5.67
US$45,360 		8,000 +14.7% 5.67 US$45,360
2026-03-04 2026-03-02 S Sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,566 -3.5%
5.42
US$30,168 		5,566 -3.5% 5.42 US$30,168
2026-03-04 2026-03-02 S Sale
2.9
ARTIS DEAN RICHARD

EVP & CHIEF SCIENTIFIC OFFICER

Officer
5,894 -3.2%
5.43
US$32,004 		5,894 -3.2% 5.43 US$32,004
2026-03-04 2026-03-02 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
5,565 -3.2%
5.42
US$30,162 		5,565 -3.2% 5.42 US$30,162
2026-03-04 2026-03-02 S Sale
2.9
Dananberg Jamie

CHIEF MEDICAL OFFICER

Officer
5,820 -4.5%
5.43
US$31,603 		5,820 -4.5% 5.43 US$31,603
2026-03-04 2026-03-02 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
4,339 -2.3%
5.42
US$23,517 		4,339 -2.3% 5.42 US$23,517
2026-03-02 2026-03-02 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
5,566
5.42
US$30,181 		5,566 5.42 US$30,181
2026-03-02 2026-03-02 PrS Proposed sale
2.9
ARTIS DEAN RICHARD

Officer

Officer
5,894
5.43
US$31,980 		5,894 5.43 US$31,980
2026-03-02 2026-03-02 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
4,339
5.42
US$23,530 		4,339 5.42 US$23,530
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Dananberg Jamie

Officer

Officer
5,820
5.43
US$31,579 		5,820 5.43 US$31,579
2026-03-02 2026-03-02 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
5,565
5.42
US$30,178 		5,565 5.42 US$30,178
2026-02-20 2026-02-18 S Sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
7,857 -7.5%
5.11
US$40,149 		7,857 -7.5% 5.11 US$40,149
2026-02-20 2026-02-18 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
6,225 -4.8%
5.10
US$31,747 		6,225 -4.8% 5.10 US$31,747
2026-02-20 2026-02-18 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
7,851 -6.5%
5.11
US$40,119 		7,851 -6.5% 5.11 US$40,119
2026-02-20 2026-02-18 S Sale
2.9
Dananberg Jamie

CHIEF MEDICAL OFFICER

Officer
5,290 -6.7%
5.10
US$26,979 		5,290 -6.7% 5.10 US$26,979
2026-02-20 2026-02-18 S Sale
2.9
ARTIS DEAN RICHARD

EVP & CHIEF SCIENTIFIC OFFICER

Officer
5,290 -4.1%
5.10
US$26,979 		5,290 -4.1% 5.10 US$26,979
2026-02-18 2026-02-18 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
7,851
5.11
US$40,119 		7,851 5.11 US$40,119
2026-02-18 2026-02-18 PrS Proposed sale
2.9
ARTIS DEAN RICHARD

Officer

Officer
5,290
5.10
US$26,990 		5,290 5.10 US$26,990
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
7,857
5.11
US$40,122 		7,857 5.11 US$40,122
2026-02-18 2026-02-18 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
6,225
5.10
US$31,764 		6,225 5.10 US$31,764
2026-02-18 2026-02-18 PrS Proposed sale
2.9
Dananberg Jamie

Officer

Officer
5,290
5.10
US$26,990 		5,290 5.10 US$26,990
2026-01-02 2025-12-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +8.2%
5.02
US$20,657 		4,115 +8.2% 5.02 US$20,657
2025-12-03 2025-12-01 B Purchase
3.3
Choi Jung
Non-Executive Director
33,000 +inf%
4.19
US$138,270 		33,000 +inf% 4.19 US$138,270
2025-12-03 2025-12-01 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +8.9%
4.47
US$18,394 		4,115 +8.9% 4.47 US$18,394
2025-11-21 2025-11-21 B Purchase
3.3
Satter Muneer A
Non-Executive Director
422,613 +4.5%
4.28
US$1,808,784 		422,613 +4.5% 4.28 US$1,808,784
2025-11-21 2025-11-20 B Purchase
3.3
Satter Muneer A
Non-Executive Director
400,000 +4.5%
4.48
US$1,792,000 		400,000 +4.5% 4.48 US$1,792,000
2025-11-19 2025-11-19 B Purchase
3.3
Satter Muneer A
Non-Executive Director
500,000 +5.9%
3.94
US$1,970,000 		500,000 +5.9% 3.94 US$1,970,000
2025-11-19 2025-11-18 B Purchase
3.3
Satter Muneer A
Non-Executive Director
500,000 +6.3%
3.18
US$1,590,000 		500,000 +6.3% 3.18 US$1,590,000
2025-11-19 2025-11-17 B Purchase
3.3
Satter Muneer A
Non-Executive Director
500,000 +6.8%
2.99
US$1,495,000 		500,000 +6.8% 2.99 US$1,495,000
2025-10-31 2025-10-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +9.8%
3.17
US$13,045 		4,115 +9.8% 3.17 US$13,045
2025-10-02 2025-09-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +10.8%
3.05
US$12,551 		4,115 +10.8% 3.05 US$12,551
2025-09-04 2025-09-02 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +12.2%
2.09
US$8,600 		4,115 +12.2% 2.09 US$8,600
2025-08-01 2025-07-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +13.8%
2.43
US$9,999 		4,115 +13.8% 2.43 US$9,999
2025-07-16 2025-07-14 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
1,117 -0.9%
2.58
US$2,882 		1,117 -0.9% 2.58 US$2,882
2025-07-16 2025-07-14 S Sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
1,116 -1.1%
2.58
US$2,879 		1,116 -1.1% 2.58 US$2,879
2025-07-16 2025-07-14 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
853 -0.6%
2.61
US$2,226 		853 -0.6% 2.61 US$2,226
2025-07-14 2025-07-14 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
1,116
2.58
US$2,881 		1,116 2.58 US$2,881
2025-07-14 2025-07-14 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
853
2.61
US$2,226 		853 2.61 US$2,226
2025-07-14 2025-07-14 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
1,117
2.58
US$2,881 		1,117 2.58 US$2,881
2025-07-01 2025-06-30 PP Planned purchase
Carson William H.
Non-Executive Director
4,115 +16.1%
2.46
US$10,123 		4,115 +16.1% 2.46 US$10,123
2025-02-20 2025-02-18 S Sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
8,345 -12.0%
2.91
US$24,284 		8,345 -12.0% 2.91 US$24,284
2025-02-20 2025-02-18 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
6,618 -7.1%
2.95
US$19,523 		6,618 -7.1% 2.95 US$19,523
2025-02-20 2025-02-18 S Sale
2.9
Dananberg Jamie

CHIEF MEDICAL OFFICER

Officer
5,521 -14.2%
2.96
US$16,342 		5,521 -14.2% 2.96 US$16,342
2025-02-20 2025-02-18 S Sale
2.9
ARTIS DEAN RICHARD

EVP & CHIEF SCIENTIFIC OFFICER

Officer
5,515 -6.2%
2.97
US$16,380 		5,515 -6.2% 2.97 US$16,380
2025-02-20 2025-02-18 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
6,912 -8.2%
2.92
US$20,183 		6,912 -8.2% 2.92 US$20,183
2025-02-18 2025-02-18 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
8,345
2.91
US$24,321 		8,345 2.91 US$24,321
2025-02-18 2025-02-18 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
8,338
2.92
US$24,319 		8,338 2.92 US$24,319
2025-02-18 2025-02-18 PrS Proposed sale
2.9
ARTIS DEAN RICHARD

Officer

Officer
5,515
2.97
US$16,359 		5,515 2.97 US$16,359
2025-02-18 2025-02-18 PrS Proposed sale
2.9
Dananberg Jamie

Officer

Officer
5,521
2.96
US$16,359 		5,521 2.96 US$16,359
2025-02-18 2025-02-18 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
6,618
2.95
US$19,514 		6,618 2.95 US$19,514
2025-02-18 2025-02-13 S Sale
3.6
Overdorf Michael

EVP & CHIEF BUSINESS OFFICER

Officer
1,425 -1.5%
2.99
US$4,261 		1,425 -1.5% 2.99 US$4,261
2025-02-18 2025-02-13 S Sale
2.7
Lew Jennifer

EVP & CHIEF FINANCIAL OFFICER

Officer
1,786 -2.1%
2.98
US$5,322 		1,786 -2.1% 2.98 US$5,322
2025-02-18 2025-02-13 S Sale
3.1
Love Douglas

PRESIDENT AND CEO

Executive Director
5,021 -1.4%
2.95
US$14,812 		5,021 -1.4% 2.95 US$14,812
2025-02-18 2025-02-13 S Sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
1,783 -2.5%
2.99
US$5,331 		1,783 -2.5% 2.99 US$5,331
2025-02-13 2025-02-13 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
1,783
2.98
US$5,316 		1,783 2.98 US$5,316
2025-02-13 2025-02-13 PrS Proposed sale
3.1
Love Douglas

Officer; Director

Executive Director
5,021
2.95
US$14,799 		5,021 2.95 US$14,799
2025-02-13 2025-02-13 PrS Proposed sale
2.7
Lew Jennifer

Officer

Officer
1,786
2.98
US$5,314 		1,786 2.98 US$5,314
2025-02-13 2025-02-13 PrS Proposed sale
3.6
Overdorf Michael

Officer

Officer
1,425
2.99
US$4,265 		1,425 2.99 US$4,265
2024-12-04 2024-12-02 PP Planned purchase
Carson William H.
Non-Executive Director
3,200 +14.3%
5.33
US$17,056 		3,200 +14.3% 5.33 US$17,056
2024-10-17 2024-10-15 PlS Planned sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,408 -7.0%
7.41
US$40,073 		5,408 -7.0% 7.41 US$40,073
2024-10-15 2024-10-15 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
5,408
7.41
US$40,073 		5,408 7.41 US$40,073
2024-10-02 2024-10-01 PP Planned purchase
Carson William H.
Non-Executive Director
3,200 +16.7%
5.97
US$19,104 		3,200 +16.7% 5.97 US$19,104
2024-09-20 2024-09-19 PlS Planned sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
4,500 -100.0%
7.10
US$31,950 		4,500 -100.0% 7.10 US$31,950
2024-09-19 2024-09-19 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
4,500
7.10
US$31,950 		4,500 7.10 US$31,950
2024-09-16 2024-09-12 PlS Planned sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,500 -55.0%
6.16
US$33,880 		5,500 -55.0% 6.16 US$33,880
2024-09-12 2024-09-12 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
5,500
6.16
US$33,880 		5,500 6.16 US$33,880
2024-09-06 2024-09-05 PlS Planned sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,500 -35.5%
5.64
US$31,020 		5,500 -35.5% 5.64 US$31,020
2024-09-05 2024-09-05 PrS Proposed sale
3.4
Yednock Ted

Officer

Officer
5,500
5.64
US$31,020 		5,500 5.64 US$31,020
2024-09-04 2024-09-03 PP Planned purchase
Carson William H.
Non-Executive Director
3,200 +20.0%
5.48
US$17,536 		3,200 +20.0% 5.48 US$17,536
2024-08-30 2024-08-29 PlS Planned sale
3.4
Yednock Ted

EVP & CHIEF INNOVATION OFFICER

Officer
5,500 -26.2%
5.95
US$32,725 		5,500 -26.2% 5.95 US$32,725
Explore more

More insider trading research around Annexon Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America